Myeloma Today June 2003 Volume 5 Issue 6
FDA Approves VELCADE® for the Treatment of Relapsed and Refractory Multiple Myeloma
Profile Interview: Julian Adams, Ph.D.
Life Lessons from a Politician
Myeloma Update: Overview of the 9th International Workshop on Multiple Myeloma International Prognostic Index, and Bank On a Cure
Q&A: Get Your Questions Answered
News & Notes
2003 IMF Anniversary Gala